/

Alamar Biosciences

Develops high-sensitivity proteomics platforms for early disease detection.

BiotechnologyMedical Technology

alamarbio.com ↗

Company facts

Founded: 2018
Employees: 187
Headquarters: United States
Type: Private
Funding: Series C · $128M · 2024